Stempoint Capital Lp - Dec 31, 2024 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares") (VTGN)

Filing Manager
STEMPOINT CAPITAL LP
Reporting Manager
StemPoint Capital LP
Security
Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares")
Symbol
VTGN
Shares outstanding
28.4M shares
Disclosed Ownership
2.33M shares
Ownership
8.2%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 01:01 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
StemPoint Capital LP 8.2% 2.33M 0 2.05M /s/ Sean C. Tan Sean C. Tan, Authorized Signatory
StemPoint Capital Management GP LLC 8.2% 2.33M 0 2.05M /s/ Sean C. Tan Sean C. Tan, Authorized Signatory
Michelle Ross 8.2% 2.33M 0 2.05M /s/ Michelle Ross Michelle Ross